Universal Health's stock experienced a significant pre-market plunge, dropping 7.25% during Thursday's pre-market trading session.

The sharp decline follows the company's release of fourth-quarter financial results that missed analyst expectations. Universal Health reported adjusted earnings per share of $5.88 for the quarter, narrowly missing the consensus estimate of $5.90, while quarterly revenue of $4.486 billion also fell short of the expected $4.502 billion. The company attributed these misses to lower-than-expected medical care demand, particularly as subsidies under Affordable Care Act plans expire, which has impacted patient volumes for elective procedures and preventive visits.

Adding to the negative sentiment, analysts have expressed concerns about weaker underlying demand, policy risks, and overvalued shares. Bank of America Securities maintained a Sell rating on the stock, citing these factors as supporting an underperform stance despite the company's strong 2025 results and generally above-expectations full-year 2026 outlook.